[ad_1]
Palo Alto Networks said it’s seeing progress as it seeks to drive customer adoption of a broader suite of services, but some investors may quibble with deceleration on a key metric.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...